142 related articles for article (PubMed ID: 8729614)
1. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
Avilés A; Delgado S; Ruiz H; de la Torre A; Guzman R; Talavera A
Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):19-23. PubMed ID: 8729614
[TBL] [Abstract][Full Text] [Related]
2. Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone.
Uematsu M; Kondo M; Hiramatsu H; Ikeda Y; Mikata S; Katayama M; Ito H; Kusano S; Kubo A
Acta Oncol; 1993; 32(6):675-8. PubMed ID: 8260187
[TBL] [Abstract][Full Text] [Related]
3. [Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
Hayabuchi N; Jingu K; Miyoshi M; Akasi Y; Masuda K; Komiyama S; Kikuchi M
Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1428-36. PubMed ID: 2212835
[TBL] [Abstract][Full Text] [Related]
4. Stage I malignant lymphoma of Waldeyer's ring: frequent relapse after radiation therapy.
Takagi T; Sampi K; Iida K
Ann Oncol; 1992 Feb; 3(2):137-9. PubMed ID: 1606083
[TBL] [Abstract][Full Text] [Related]
5. [Non-Hodgkin's lymphoma of the Waldeyer's ring: the treatment results of the past 22 years and the significance of CHOP].
Hiramatsu H; Kondo M; Uematsu M; Shigematsu N; Ando Y; Hashimoto S
Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2477-83. PubMed ID: 2262731
[TBL] [Abstract][Full Text] [Related]
6. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
Eifel PJ; McClure S
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
[No Abstract] [Full Text] [Related]
7. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
8. [Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
Sampi K; Takagi T; Morii K; Hattori M
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2345-9. PubMed ID: 8259849
[TBL] [Abstract][Full Text] [Related]
9. Management of stage I-II diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring: combined modality therapy versus radiotherapy alone.
Liang R; Ng RP; Todd D; Choy D; Khoo RK; Ho FC
Hematol Oncol; 1987; 5(3):223-30. PubMed ID: 3653859
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphoma of Waldeyer's ring.
Albada J; Hordijk GJ; van Unnik JA; Dekker AW
Cancer; 1985 Dec; 56(12):2911-3. PubMed ID: 3840405
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring.
Chang DT; Mendenhall NP; Lynch JW; Morris CG; Olivier KR
Am J Clin Oncol; 2009 Jun; 32(3):233-7. PubMed ID: 19433961
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and therapeutic efficacy of combined radio-chemotherapy in Waldeyer's ring non-Hodgkin lymphoma.
Yong W; Zhang Y; Zheng W; Wei Y
Chin Med J (Engl); 2000 Feb; 113(2):148-50. PubMed ID: 11775540
[TBL] [Abstract][Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
15. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
[TBL] [Abstract][Full Text] [Related]
16. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
Munck JN; Dhermain F; Koscielny S; Girinsky T; Carde P; Bosq J; Decaudin D; Juliéron M; Cosset JM; Hayat M
Ann Oncol; 1996 Nov; 7(9):925-31. PubMed ID: 9006743
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
18. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
[TBL] [Abstract][Full Text] [Related]
19. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
J Clin Oncol; 1993 Apr; 11(4):720-5. PubMed ID: 8478665
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring.
Harabuchi Y; Tsubota H; Ohguro S; Himi T; Asakura K; Kataura A; Ohuchi A; Hareyama M
Acta Oncol; 1997; 36(4):413-20. PubMed ID: 9247103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
